Search

Author/Creator Nowak, V.

2. 227 CD71+ ERYTHROPROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES DISPLAY DISTURBED REGULATION OF ERYTHROPOIESIS STIMULATING ERYTHROFERRONE (ERFE) IN ASSOCIATION WITH DIFFERENTIAL PROGNOSTIC SIGNIFICANCE. Issue 1 (April 2015)

Authors:
Mossner, M.; Stöhr, A.; Nolte, F.; Jann, J.C.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Baldus, C.D.; Schulze, T.J.; Neumann, M.; Nowak, D.; Hofmann, W.K.
Journal:
Leukemia research
Issue:
Volume 39:Issue 1(2015:Jan.)
Page Start:
S113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 5-AZACYTIDINE IN COMBINATION WITH A NOVEL PAN-LYSYL OXIDASE INHIBITOR SYNERGISTICALLY RESTORES ERYTHROPOIESIS IN MYELODYSPLASTIC MALIGNANCIES. (May 2023)

Authors:
Xu, Q.; Streuer, A.; Jann, J.-C.; Altrock, E.; Schmitt, N.; Flach, J.; Sens-Albert, C.; Rapp, F.; Wolf, J.; Nowak, V.; Weimer, N.; Obländer, J.; Palme, I.; Kuzina, M.; Jawhar, A.; Darwich, A.; Weis, C.-A.; Marx, A.; Wuchter, P.; Costina, V.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 65 MYELODYSPLASTIC SYNDROMES ARE CHARACTERIZED BY RECURRENT PATTERNS IN PATIENT-INDIVIDUAL MUTATIONAL HIERARCHIES THAT ARE SUBJECT TO HIGHLY DYNAMIC SUBCLONAL EVOLUTION DURING THERAPY AND DISEASE PROGRESSION. (April 2015)

Authors:
Mossner, M.; Jann, J.C.; Wittig, J.; Nolte, F.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Müdder, K.; Klein, C.; Zens, B.; Platzbecker, U.; Schönefeldt, C.; Fabarius, A.; Blum, H.; Schulze, T.J.; Haferlach, C.; Trumpp, A.; Hofmann, W.K.; Medyouf, H.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S32
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Erythroferrone (ERFE) and Growth Differentiation Factor 15 (GDF15) Are Overexpressed in Erythroprogenitor Cells of MDS Patients and Associated with Survival. (April 2017)

Authors:
Mossner, M.; Stöhr, A.; Jann, J.C.; Nolte, F.; Nowak, V.; Oblaender, J.; Pressler, J.; Xanthopoulos, C.; Palme, I.; Baldus, C.; Schulze, T.; Boch, T.; Metzgeroth, G.; Neumann, M.; Hofmann, W.K.; Nowak, D.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S100
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Proceedings of the 2014 Autumn Meeting of the Society of British Neurological Surgeons. (October 2014)

Authors:
Jenkinson, M. D.; Waqar, M.; Farrell, M.; Barbagallo, G. M. V.; Certo, F.; McManus, R.; Looby, S.; Hussey, D.; Fitzpatrick, D.; Javadpour, M.; Mallucci, C.; Zebian, B.; Jenkinson, M. D.; Gamble, C.; Hickey, H.; Ibrahim, A.; Fehlings, M. G.; on behalf of the CSM-I Investigators; Wilby, M.; Kabwama...
Journal:
British journal of neurosurgery
Issue:
Volume 28:Number 5(2014:Oct.)
Page Start:
568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX): OPTIMIZATION OF MDS PATIENT-DERIVED XENOGRAFT (PDX) MODELS BY COMPARISON OF NSG AND NBSGW MICE. (May 2023)

Authors:
Schmitt, N.; Streuer, A.; Danner, J.; Altrock, E.; Riabov, V.; Xu, Q.; Rapp, F.; Weimer, N.; Palme, I.; Nowak, V.; Obländer, J.; Göl, M.; Darwich, A.; Steiner, L.; Boch, T.; Jawhar, M.; Metzgeroth, G.; Hofmann, W.-K.; Nowak, D.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: BONE MARROW DERIVED STROMAL CELLS FROM MYELODYSPLASTIC SYNDROMES ARE ALTERED BUT NOT CLONALLY MUTATED IN VIVO. (September 2021)

Authors:
Jann, J.-C.; Mossner, M.; Flach, J.; Altrock, E.; Schmitt, N.; Ryabov, V.; Xu, Q.; Nowak, V.; Obländer, J.; Palme, I.; Weimer, N.; Streuer, A.; Jawhar, A.; Darwich, A.; Metzgeroth, G.; Nolte, F.; Hofmann, W.-K.; Nowak, D.
Journal:
Leukemia research
Issue:
Volume 108(2021)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS. (May 2023)

Authors:
Ryabov, V.; Xu, Q.; Schmitt, N.; Streuer, A.; Ge, G.; Bolanos, L.; Wunderlich, M.; Jann, J.-C.; Wein, A.; Altrock, E.; Mukherjee, S.; Ali, A.M.; Rapp, F.; Nowak, V.; Weimer, N.; Obländer, J.; Palme, I.; Göl, M.; Jawhar, A.; Darwich, A.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Topic: AS08-Treatment/AS08e-New developments - Preclinical studies: A PRE-CLINICAL PATIENT-DERIVED XENOGRAFT MODEL OF MYELODYSPLASTIC SYNDROMES DEMONSTRATES EFFICACY AND SAFETY OF ELTROMBOPAG. (September 2021)

Authors:
Schmitt, N.; Jann, J.-C.; Altrock, E.; Flach, J.; Danner, J.; Uhlig, S.; Streuer, A.; Knaflic, A.; Riabov, V.; Xu, Q.; Mehralivand, A.; Palme, I.; Nowak, V.; Oblaender, J.; Weimer, N.; Haselmann, V.; Jawhar, A.; Darwich, A.; Weis, C.-A.; Marx, A.
Journal:
Leukemia research
Issue:
Volume 108(2021)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗